Innate immunity cell receptors can be activated by the above sphingolipid to affect the physiological and pathological processes of IBD, such as TLR, PPARα/γ, AhR, Gprotein-coupled receptors, and endogenous cannabinoids [52, 55]. The gene discussed is PPARA; the disease is inflammatory bowel disease.